Analyst Research

Report Title Price
Provider: New Constructs, LLC
Provider: S&P Capital IQ Quantitative Report
Provider: Pechala's Reports
Provider: Reuters Investment Profile

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Solazyme Inc Issues FY 2013 Revenue Guidance Below Analysts' Estimates-Conference Call

Wednesday, 20 Feb 2013 09:30pm EST 

Solazyme Inc announced that for fiscal 2013, it expects overall revenue growth of approximately 25%. The Company reported revenue of $44.11 million in fiscal 2012. According to I/B/E/S Estimates, analysts on an average are expecting the Company to report revenue of $82.05 million for fiscal 2013. 

Company Quote

-0.23 -2.01%
17 Apr 2014